Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Appendicitis Inflammatory Response (AIR) score for diagnosis in adults and children LOE 1A
    Decision Support Tools, 11-Jul-2019
  • Appendicitis: identification of low risk children (PALabS score) LOE 1a
    Decision Support Tools, 1-Jun-2022
  • Appendicitis: ruling out in adults with indeterminate USN LOE 1a
    Decision Support Tools, 2-Jul-2015
  • Asthma prediction in preschool children LOE 1a
    Decision Support Tools, 2-Jul-2014
  • Asthma relapse in adults LOE 1a
    Decision Support Tools, 1-Jun-2002
  • Atrial fib risk post-op CABG LOE 1a
    Decision Support Tools, 1-Jun-2010
  • Atrial fibrillation risk (10 year) LOE 2a
    Decision Support Tools, 1-Jun-2010
  • AUDIT-C (alcohol use disorder screen) LOE 1a
    Decision Support Tools, 1-Sep-2003
  • AV replacement in aortic stenosis LOE 1a
    Decision Support Tools, 1-Sep-1994
  • Avian flu (H76N9) diagnosis LOE 1a
    Decision Support Tools, 1-Nov-2016
  • Back pain evaluation guideline LOE 1a
    Decision Support Tools, 1-Dec-2002
  • Bacteremia risk (age 3 to 36 months) LOE 1a
    Decision Support Tools, 1-Feb-2004
  • Bacteremia risk in older patients with CAP LOE 1a
    Decision Support Tools, 1-Jun-2004
  • Bariatric surgery risk score LOE 1a
    Decision Support Tools, 1-Jun-2010
  • Basal energy requirements LOE 5
    Decision Support Tools, 1-Sep-1994
  • Benefit from spinal manipulation LOE 2a
    Decision Support Tools, 1-Aug-2006
  • Benefit of prolonged DAPT following PCI (DAPT score) LOE 1a
    Decision Support Tools, 1-Jun-2018
  • Bilirubin prediction based on initial level LOE 1a
    Decision Support Tools, 1-Aug-2005
  • Bipolar disorder (Mood Disorder Questionnaire) LOE 1a
    Decision Support Tools, 1-Dec-2005
  • Bladder cancer prognosis LOE 2a
    Decision Support Tools, 1-Dec-2005
[x]

Login or Subscribe

Login

Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More